AKT1 and head and neck squamous cell carcinoma: The findings that PI3K signalling is frequently altered in more aggressive SCCs such as HNSCC, lung and oesophageal SCC11 further supports our MD/PD pathway analysis implicating PI3K-AKT signalling in disease progression.